metformin has been researched along with Autoimmune Thrombocytopenia in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Excerpt | Relevance | Reference |
---|---|---|
" Previous reports indicate that ELT is mainly eliminated in the liver, although its pharmacokinetic profile has not yet been clarified in detail." | 1.37 | Pharmacokinetics and hepatic uptake of eltrombopag, a novel platelet-increasing agent. ( Horikawa, M; Ishiwata, N; Kato, Y; Matsubara, K; Nakamichi, N; Silver, DL; Sugiura, T; Takeuchi, K; Umeda, S, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Takeuchi, K | 1 |
Sugiura, T | 1 |
Umeda, S | 1 |
Matsubara, K | 1 |
Horikawa, M | 1 |
Nakamichi, N | 1 |
Silver, DL | 1 |
Ishiwata, N | 1 |
Kato, Y | 1 |
1 other study available for metformin and Autoimmune Thrombocytopenia
Article | Year |
---|---|
Pharmacokinetics and hepatic uptake of eltrombopag, a novel platelet-increasing agent.
Topics: Animals; Benzoates; Blood Platelets; Cell Line; Dose-Response Relationship, Drug; Hepatocytes; Human | 2011 |